Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-7b9c58cd5d-wdhn8 Total loading time: 0 Render date: 2025-03-13T13:17:48.673Z Has data issue: false hasContentIssue false

Domperidone

Published online by Cambridge University Press:  20 February 2025

K. Ray Chaudhuri ,
Peter Jenner ,
Valentina Leta ,
Shelley Jones  and
Iro Boura
K. Ray Chaudhuri
Affiliation:
King's College London
Peter Jenner
Affiliation:
King's College London
Valentina Leta
Affiliation:
King's College London
Shelley Jones
Affiliation:
King's College London
Iro Boura
Affiliation:
St. George General Hospital of Chania, Crete, Greece
Get access

Summary

Domperidone (6-chloro-3-[1-[3-(2-oxo-3H-benzimidazol-1-yl)propyl]piperidin-4-yl]-1H-benzimidazol-2-one) has a molecular weight of 425.9 and an empirical formula of C22H24ClN5O2. Each tablet contains domperidone maleate 10 mg, which is equivalent to 10 mg domperidone base.

Type
Chapter
Information
The Movement Disorders Prescriber's Guide to Parkinson's Disease , pp. 116 - 125
Publisher: Cambridge University Press
Print publication year: 2025

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Suggested Reading

Jansen, PA, Herings, RM, Samson, MM, De Vreede, PL, Schuurmans-Daemen, LM, Hovestadt, A, Verhaar, HJ, Van Laar, T. Quick titration of pergolide in cotreatment with domperidone is safe and effective. Clin Neuropharmacol 2001; 24(3): 177–180.CrossRefGoogle ScholarPubMed
Langdon, N, Malcolm, PN, Parkes, JD. Comparison of levodopa with carbidopa, and levodopa with domperidone in Parkinson’s disease. Clin Neuropharmacol 1986; 9(5): 440–447.CrossRefGoogle ScholarPubMed
Quinn, N, Illas, A, Lhermitte, F, Agid, Y. Bromocriptine and domperidone in the treatment of Parkinson disease. Neurology 1981; 31(6): 662–667.CrossRefGoogle Scholar
Schoffer, KL, Henderson, RD, O’Maley, K, O’Sullivan, JD. Nonpharmacological treatment, fludrocortisone, and domperidone for orthostatic hypotension in Parkinson’s disease. Mov Disord 2007; 22(11): 1543–1549.CrossRefGoogle ScholarPubMed

References

AHFS Drug information, 2012. Bethesda: American Society of Health-System Pharmacists. Accessed on 12 December 2022 via www.medicinescomplete.com.Google Scholar
Bacchi, S, Chim, I, Kramer, P, Postuma, RB. Domperidone for hypotension in Parkinson’s disease: a systematic review. J Parkinsons Dis 2017; 7(4): 603–617.CrossRefGoogle ScholarPubMed
Barone, JA. Domperidone: a peripherally acting dopamine2-receptor antagonist. Ann Pharmacother 1999; 33(4): 429–440.CrossRefGoogle ScholarPubMed
Domperidone, in Drugs and Lactation Database (LactMed). 2022, National Library of Medicine (US): Bethesda (MD).Google Scholar
Domperidone. In: Brayfield, A (Ed.), Martindale: The Complete Drug Reference. London: The Royal Pharmaceutical Society of Great Britain. Accessed on 12 December 2022 via www.medicinescomplete.com.Google Scholar
Domperidone. In: DRUGDEX® System (electronic version). Truven Health Analytics, Greenwood Village, Colorado, USA. Accessed on 12 December 2022 via www.micromedexsolutions.com.Google Scholar
Joint Formulary Committee. British National Formulary (online). London: BMJ Group and Pharmaceutical Press. Accessed on 12 December 2022 via www.medicinescomplete.com.Google Scholar
Reddymasu, SC, Soykan, I, McCallum, RW. Domperidone: review of pharmacology and clinical applications in gastroenterology. Am J Gastroenterol 2007; 102(9): 2036–2045.CrossRefGoogle ScholarPubMed
Renoux, C, Dell’Aniello, S, Khairy, P, Marras, C, Bugden, S, Turin, TC, Blais, L, Tamim, H, Evans, C, Steele, R, Dormuth, C, Ernst, P. Ventricular tachyarrhythmia and sudden cardiac death with domperidone use in Parkinson’s disease. Br J Clin Pharmacol 2016; 82(2): 461–472.CrossRefGoogle ScholarPubMed
Rios Romenets, S, Dauvilliers, Y, Cochen De Cock, V, Carlander, B, Bayard, S, Galatas, C, Wolfson, C, Postuma, RB. Restless legs syndrome outside the blood–brain barrier – exacerbation by domperidone in Parkinson’s disease. Parkinsonism Relat Disord 2013; 19(1): 92–94.CrossRefGoogle ScholarPubMed
Simeonova, M, de Vries, F, Pouwels, S, Driessen, JHM, Leufkens, HGM, Cadarette, SM, Burden, AM. Increased risk of all-cause mortality associated with domperidone use in Parkinson’s patients: a population-based cohort study in the UK. Br J Clin Pharmacol 2018; 84(11): 2551–2561.CrossRefGoogle ScholarPubMed
Song, BG, Lee, YC, Min, YW, Kim, K, Lee, H, Son, HJ, Rhee, PL. Risk of domperidone induced severe ventricular arrhythmia. Sci Rep 2020; 10(1): 12158.CrossRefGoogle ScholarPubMed
Summary of Product Characteristics – Motilium 10 mg film-coated tablets. Zentiva. Electronic Medicines Compendium: Motilium 10 mg film-coated tablets – summary of product characteristics (SmPC) – (emc). Accessed on 12 December 2022 via www.medicines.org.uk.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Domperidone
  • K. Ray Chaudhuri, King's College London, Peter Jenner, King's College London, Valentina Leta, King's College London, Shelley Jones, King's College London, Iro Boura, St. George General Hospital of Chania, Crete, Greece
  • Book: The Movement Disorders Prescriber's Guide to Parkinson's Disease
  • Online publication: 20 February 2025
  • Chapter DOI: https://doi.org/10.1017/9781009222648.013
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Domperidone
  • K. Ray Chaudhuri, King's College London, Peter Jenner, King's College London, Valentina Leta, King's College London, Shelley Jones, King's College London, Iro Boura, St. George General Hospital of Chania, Crete, Greece
  • Book: The Movement Disorders Prescriber's Guide to Parkinson's Disease
  • Online publication: 20 February 2025
  • Chapter DOI: https://doi.org/10.1017/9781009222648.013
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Domperidone
  • K. Ray Chaudhuri, King's College London, Peter Jenner, King's College London, Valentina Leta, King's College London, Shelley Jones, King's College London, Iro Boura, St. George General Hospital of Chania, Crete, Greece
  • Book: The Movement Disorders Prescriber's Guide to Parkinson's Disease
  • Online publication: 20 February 2025
  • Chapter DOI: https://doi.org/10.1017/9781009222648.013
Available formats
×